At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 120 enrolled
Drug / intervention
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg +3 moredrug
Likely dose
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magnesium Hydroxide) Alone
In Brief
A Phase 2 clinical trial evaluating Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg, Lansoprazole, and 2 other interventions for Heartburn. Completed, enrolled 120 participants across 1 site.
Detailed Summary
This study will investigate the safety and efficacy of an antacid/Lansoprazole combination product for the relief of heartburn after consuming a heartburn-inducing meal.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeartburn
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2009
First PostedDec 2009
Primary CompletionJan 2010
TodayJul 2026
First PostedDec 23, 2009
Enrollment StartDec 1, 2009
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.5 years ago
Interventions
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mgdrug
Tablet
Lansoprazoledrug
Tablet
Calcium carbonate/magnesium hydroxidedrug
Tablet
Placebodrug
Tablet